Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
The American Journal of Psychiatry|July 1, 1992
Replication of action of cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findingsJ Bradwejn, D Koszycki, R Payeur, et al.Journal of Psychopharmacology (Oxford, England)|February 10, 2000
Effects of CCK-4 infusion on the acoustic eye-blink startle and psychophysiological measures in healthy volunteersJ Shlik, Y Zhou, D Koszycki, et al.Depression and Anxiety|September 29, 1998
Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickersD Koszycki, R M Zacharko, J M Le Mellédo, et al.Peptides|July 18, 2001
Arginine-vasopressin and oxytocin response to cholecystokinin-tetrapeptideJ M Le Mellédo, J Bradwejn, D Koszycki, et al.Biological Psychiatry|December 1, 1995
Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteersJ Bradwejn, D Koszycki, M Paradis, et al.Psychopharmacology|March 1, 1994
Effects of flumazenil on cholecystokinin-tetrapeptide-induced panic symptoms in healthy volunteersJ Bradwejn, D Koszycki, A Couëtoux du Tertre, et al.The American Journal of Psychiatry|February 17, 1998
Effects of cholecystokinin tetrapeptide on respiratory function in healthy volunteersJ Bradwejn, J M LeGrand, D Koszycki, et al.Biological Psychiatry|October 2, 1998
The role of the beta-noradrenergic system in cholecystokinin-tetrapeptide-induced panic symptomsJ M Le Mellédo, J Bradwejn, D Koszycki, et al.Biological Psychiatry|November 15, 1992
A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorderJ Bradwejn, D Koszycki, L Annable, et al.Biological Psychiatry|October 1, 1996
Effect of acute tryptophan depletion on behavioral, cardiovascular, and hormonal sensitivity to cholecystokinin-tetrapeptide challenge in healthy volunteersD Koszycki, R M Zacharko, J M Le Melledo, et al.Pageof 4